Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials.

Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials.

Item

http://www.wikidata.org/entity/Q33836604

Q33836604

about

Antihypertensive treatment and renal protection: the role of drugs inhibiting the renin-angiotensin-aldosterone system Cardiovascular risk factor treatment targets and renal complications in high risk vascular patients: a cohort study.Proteinuria is associated with neurocognitive impairment in antiretroviral therapy treated HIV-infected individuals Assessment and management of resistant hypertension Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.Active vitamin D treatment for reduction of residual proteinuria: a systematic review.Emerging drug combinations to optimize renovascular protection and blood pressure goals.RAS-Mediated Adaptive Mechanisms in Cardiovascular Tissues: Confounding Factors of RAS Blockade Therapy and Alternative Approaches.Wnt/β-catenin signaling and renin-angiotensin system in chronic kidney disease.Renoprotective effect of combined inhibition of angiotensin-converting enzyme and histone deacetylase.The arrestin-selective angiotensin AT1 receptor agonist [Sar1,Ile4,Ile8]-AngII negatively regulates bradykinin B2 receptor signaling via AT1-B2 receptor heterodimers Dual renin-angiotensin system inhibition for prevention of renal and cardiovascular events: do the latest trials challenge existing evidence?Renin-angiotensin system blocking drugs.Targeting angiotensin-converting enzyme 2 as a new therapeutic target for cardiovascular diseases.Defining, Treating, and Understanding Chronic Kidney Disease--A Complex Disorder.Resistant Hypertension and Chronic Kidney Disease: a Dangerous Liaison.Heparanase: roles in cell survival, extracellular matrix remodelling and the development of kidney disease.Hypertension in Chronic Kidney Disease.The Blocking on the Cathepsin B and Fibronectin Accumulation in Kidney Glomeruli of Diabetic Rats Time-varying maximal proteinuria correlates with adverse cardiovascular events and graft failure in kidney transplant recipients.Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.Effect of renin-angiotensin-aldosterone system blockade in adults with diabetes mellitus and advanced chronic kidney disease not on dialysis: a systematic review and meta-analysis.Approach to cardiovascular disease prevention in patients with chronic kidney disease.Impact of achieved blood pressure on renal function decline and first stroke in hypertensive patients with chronic kidney disease.The effects of single and combined application of ramipril and losartan on renal structure and function in hypertensive rats.

P2860

Q26865691-2C88C098-387D-407B-BF75-78C55983B080 Q33950911-0D92A06A-DD63-4269-9FB9-1A0992C7CA30 Q34048920-36FD5137-A509-43C9-BA70-FB5915E75499 Q34656780-40D510FF-C206-4B06-92A5-960D135F34D8 Q34736194-BB28B8C4-1855-4ABA-954A-E03997D94A1D Q34912750-961E0CBA-9BBA-40F9-ACED-9A5084A48A6E Q35905899-71B90591-1760-4C96-8098-290E44257834 Q36551388-64F9A7C2-E5BB-4F49-B16C-ACE4E5656569 Q36630037-954D5191-DA09-4A1A-9820-4CF82D6FF5F1 Q36796579-7B1F1AD8-26AD-4ED3-A502-EF4ADE217D5A Q36967299-83AE16F1-FCCC-4B7B-BAA1-E83955C18DB4 Q37053287-C7B5539D-6C11-42F4-A688-765E1B84BA47 Q38137851-FCA476FB-ABFE-4EB5-95C2-F80F59103FAD Q38214892-612092A7-052A-40ED-A737-65FFAB49F776 Q38445037-BFBDE182-6B09-4347-A1C2-44542CAF15D4 Q38806963-98BBD632-87B5-4666-9716-852A53DBB063 Q39120713-5887AD6D-D3A6-4980-B79F-1DE6B8382A45 Q39165623-74339A70-75EC-4775-AD42-62680C6EE1B9 Q41552405-A61A4BC5-C338-4771-A9E0-BB98BB0057A1 Q41696181-C191EF0F-5F2C-4624-B971-404B81855946 Q48347744-781569EC-FB4C-43F1-A22D-0E8738B6EA7C Q49048863-BE51D405-4D2B-4923-A38B-01C78E23848E Q49136022-80A4F50F-1135-43BE-9AB7-A24EAD7AE28F Q50074639-7789EA92-9E6D-461C-9FD7-A30ADE3DD74D Q51771875-5D83C2DF-4F39-46C8-9C4B-A2BF940CD5F7

P2860

Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials.

Item

http://www.wikidata.org/entity/Q33836604

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu